In-vitro Diagnostics Market - by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious

In-vitro Diagnostics Market - by Product Type (Instruments and Reagents & Kits), by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Urinalysis, and Others), by Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Disorders, and Others), by End User (Hospital, Pathology Laboratories, Point-of-Care Diagnostics, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast, 2022 - 2028

In-vitro diagnostics is used as a diagnostic tool by clinicians for faster diagnosis and to ensure timely treatment for patients. According to the U.S. FDA, in-vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequela. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.
Market Dynamics
Increasing product approval by market players is a major factor driving global in-vitro diagnostics market growth. For instance, in 2021, Bio-Rad Laboratories announced the U.S. Food and Drug Administration (FDA) clearance of BioPlex 2200 Syphilis Total and RPR Assay, which is a novel one-step universal testing method based on automated Treponemal/ non-Treponemal dual assay to aid in the syphilis infection.
Furthermore, inorganic strategies adopted by key players for enhancing their distribution network and offering best products in the market is expected to drive the market growth. For instance, in January 2018, Atomo Diagnostics and Access Bio partnered to expand their coverage in regions across Africa, South East Asia, and South America. The collaboration aims to access HIV infected population in these regions to market HIV rapid testing products.
Key features of the study:
This report provides in-depth analysis of the global in-vitro diagnostics market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global in-vitro diagnostics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMérieux S.A., Becton Dickinson, and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray, Inc., Nittobo Medical Co., Ltd., Medical & Biological Laboratories Co., Ltd., Miraca Holdings Inc., and Mizuho Medy Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in-vitro diagnostics market
Detailed Segmentation:
Global In-Vitro Diagnostics Market, By Product Type:
Instruments
Reagents & Kits
Blocking Buffers
Proteins
Secondary Antibodies
Substrates
Others
Global In-Vitro Diagnostics Market, By Technology:
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation & Hemostasis
Urinalysis
Others
Global In-Vitro Diagnostics Market, By Application:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disorders
Others
Global In-Vitro Diagnostics Market, By End User:
Hospital
Pathology Laboratories
Point-of-Care Diagnostics
Research Institutes
Others
Global In-Vitro Diagnostics Market, By Region:
North America
By Product Type:
Instruments
Reagents & Kits
Blocking Buffers
Proteins
Secondary Antibodies
Substrates
Others
By Technology:
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation & Hemostasis
Urinalysis
Others
By Application:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disorders
Others
By End User:
Hospital
Pathology Laboratories
Point-of-Care Diagnostics
Research Institutes
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Instruments
Reagents & Kits
Blocking Buffers
Proteins
Secondary Antibodies
Substrates
Others
By Technology:
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation & Hemostasis
Urinalysis
Others
By Application:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disorders
Others
By End User:
Hospital
Pathology Laboratories
Point-of-Care Diagnostics
Research Institutes
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Instruments
Reagents & Kits
Blocking Buffers
Proteins
Secondary Antibodies
Substrates
Others
By Technology:
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation & Hemostasis
Urinalysis
Others
By Application:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disorders
Others
By End User:
Hospital
Pathology Laboratories
Point-of-Care Diagnostics
Research Institutes
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Instruments
Reagents & Kits
Blocking Buffers
Proteins
Secondary Antibodies
Substrates
Others
By Technology:
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation & Hemostasis
Urinalysis
Others
By Application:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disorders
Others
By End User:
Hospital
Pathology Laboratories
Point-of-Care Diagnostics
Research Institutes
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Instruments
Reagents & Kits
Blocking Buffers
Proteins
Secondary Antibodies
Substrates
Others
By Technology:
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation & Hemostasis
Urinalysis
Others
By Application:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disorders
Others
By End User:
Hospital
Pathology Laboratories
Point-of-Care Diagnostics
Research Institutes
Others
By Country/Region:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Instruments
Reagents & Kits
Blocking Buffers
Proteins
Secondary Antibodies
Substrates
Others
By Technology:
Immunoassay
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hematology
Coagulation & Hemostasis
Urinalysis
Others
By Application:
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disorders
Others
By End User:
Hospital
Pathology Laboratories
Point-of-Care Diagnostics
Research Institutes
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Siemens Healthineers*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Sysmex Corporation
Bio-Rad Laboratories
BioMérieux S.A.
Becton Dickinson, and Company
Danaher Corporation
Abbott Laboratories
F. Hoffmann-la Roche Ltd
QIAGEN N.V.
Arkray, Inc.
Nittobo Medical Co., Ltd.
Medical & Biological Laboratories Co., Ltd.
Miraca Holdings Inc.
Mizuho Medy Co., Ltd.
“*” marked represents similar segmentation in other categories in the respective section.